The consultant neurologist at the National Neuroscience Institute discussed how artificial intelligence, biomarker development, and drug repurposing can help improve patient care in ALS. [WATCH TIME: 4 minutes]
Crystal Yeo, MD, PhD
Advertisement
Consultant neurologist at the National Neuroscience Institute.
Articles by Crystal Yeo, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 1/2a Findings Lend Support for BB-301 in Oculopharyngeal Muscular Dystrophy
2
Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome
3
FDA Grants Orexin Agonist Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1
4
Newer Oral Levodopa Formulations in Parkinson’s Disease
5